TDAC
Income statement / Annual
Last year (2024), Translational Development Acquisition Corp.'s total revenue was $1.07 T,
and the percentage change from the previous year is not available.
In 2024, Translational Development Acquisition Corp.'s net income was -$71.01 K.
See Translational Development Acquisition Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
| Operating Revenue |
$1.07 T |
$0.00 |
$0.00 |
| Cost of Revenue |
$320.87 B
|
$0.00
|
$0.00
|
| Gross Profit |
$744.92 B
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0.7
|
0
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$9.13 T
|
$485.55 K
|
$70.66 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$196.36 K
|
$485.55 K
|
$70.66 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$196.36 K
|
$485.55 K
|
$70.66 K
|
| Cost And Expenses |
-$196.36 K
|
$485.55 K
|
$70.66 K
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$508.56 B
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$0.00
|
$70.66 K
|
| EBITDA |
-$71.01 K |
-$485.55 K |
$0.00 |
| EBITDA Ratio |
-0
|
0
|
0
|
| Operating Income Ratio |
-0
|
0
|
0
|
| Total Other Income/Expenses Net |
$125.35 K
|
$0.00
|
$0.00
|
| Income Before Tax |
-$71.01 K
|
-$485.55 K
|
-$70.66 K
|
| Income Before Tax Ratio |
-0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$71.01 K
|
-$485.55 K
|
-$70.66 K
|
| Net Income Ratio |
-0
|
0
|
0
|
| EPS |
-0.0162 |
-0.12 |
-0.0174 |
| EPS Diluted |
-0.0162 |
-0.12 |
-0.0174 |
| Weighted Average Shares Out |
$4.05 M
|
$4.05 M
|
$4.05 M
|
| Weighted Average Shares Out Diluted |
$4.05 M
|
$4.05 M
|
$4.05 M
|
| Link |
|
|
|
